Indication: Infection

A Phase 1, Non-comparative, Open-Label Study of Pharmacokinetics and Safety of a Single-Dose of ZTI-01 (Fosfomycin for Injection) in Pediatric Subjects (Less than 12 Years of Age) Receiving Standard of Care Antibiotic Therapy for Proven or Suspected Infec

Sub-indication: Infection

Drug Study

Principal Investigator: Janice Sullivan, M.D.
Norton Children's Critical Care, affiliated with the UofL School of Medicine

Sponsor: Zavante Therapeutics, Inc.

Search our entire site.